16
Mar
EverHint Lens - CytomX Therapeutics, Inc. (CTMX) - Top Gainer (+71%) Stock Analysis - March 16, 2026
CytomX Therapeutics, Inc. (CTMX): Healthcare company. trading at $8.01, up 71.2% (on Colorectal Cancer Data).
3 min read